Chronic Hepatitis bNCT07169656
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
An observational study of Chronic Hepatitis b, run by The First Affiliated Hospital of Zhengzhou University at 162 sites in China.
Trial summary
This study is a multicenter, prospective, observational real-world study designed to investigate and analyze the current treatment patterns of chronic hepatitis B (CHB) across 200 hospitals in China. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chronic Hepatitis b
- What is being tested?
- ETV,TDF,TAF,TMF and Peginterferon α-2b injection
- Type of treatment
- Injection or infusion
- How many people
- 15,000 participants
- Where
- 162 sitesChina
- Study dates
- 3 Jun 2024to 31 Dec 2032
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients were selected from chronic hepatitis B (CHB) cases across 200 national hospitals
Who may be able to join
- 1.Chronic HBV infection (HBsAg-positive for ≥6 months); 2.Age ≥18 years; 3.Patients who, based on real-world clinical practice needs, are planned or currently receiving treatment with:Entecavir (ETV),Tenofovir disoproxil fumarate (TDF),Tenofovir alafenamide fumarate (TAF),Tenofovir amibufenamide (TMF) OR Pegylated interferon α-2b-naïve patients OR Patients re-initiating pegylated interferon α-2b therapy; 4.Written informed consent obtained from the patient.
Who cannot join
- 1.Severe hepatic dysfunction or decompensated cirrhosis; 2.Concurrent participation in other clinical trials; 3.Hepatocellular carcinoma (HCC).
Trial locations and contacts
162 sites in 1 country. Contact the study team or a site near you to ask about taking part.
162 sites in 1 country
China162 sites, 162 recruiting
- Recruiting
Huaxian People's Hospital
Anyang
Chongwei Hu
- Recruiting
Linzhou City People's Hospital
Anyang
Mingye Liu
- Recruiting
Neihuang County People's Hospital
Anyang
Jinxiu Li
- Recruiting
Tangyin County People's Hospital
Anyang
Fengge Yin
- Recruiting
The Fifth People's Hospital of Anyang
Anyang
Yuzhong Wang
- Recruiting
The First Affiliated Hospital of Xinxiang Medical University (Hua County Branch)
Anyang
Hengwei Ji
- Recruiting
Guangzhou First People's Hospital
Guangzhou
Qi Zhan
- Recruiting
The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital)
Guangzhou
Xujing Liang
- Recruiting
Hebi Coal Mining Group General Hospital
Hebi
Zhanfeng Xie
- Recruiting
Hebi Infectious Disease Hospital
Hebi
Weili Niu
- Recruiting
Junxian County People's Hospital
Hebi
Yunli Jia
- Recruiting
Bo'ai County People's Hospital
Jiaozuo
Daqing Guo
- Recruiting
Mengzhou Hospital of Traditional Chinese Medicine
Jiaozuo
Zengyuan Fu
- Recruiting
Qinyang People's Hospital
Jiaozuo
Donghai Chen
- Recruiting
The Secend People's Hospital of Jiaozuo
Jiaozuo
Yuliang Zhao
- Recruiting
The Third People's Hospital of Jiaozuo
Jiaozuo
Zhiqi Han
- Recruiting
Xiuwu People's Hospital
Jiaozuo
Chao Zhang
- Recruiting
Wenxian People's Hospital
Jiayuguan
Guoqing Chen
- Recruiting
Jiyang County Hospital of Traditional Chinese Medicine
Jinan
Jian Yao
- Recruiting
Shandong Public Health Clinical Center
Jinan
Xiaoying Li
- Recruiting
Jiyuan People's Hospital
Jiyuan
Chao Liang
- Recruiting
Jiyuan Traditional Chinese Medicine Hospital
Jiyuan
Yuye Wu
- Recruiting
Huaihe Hospital of Henan University
Kaifeng
Zhenkun He
- Recruiting
Infectious Diseases Hospital of Kaifeng
Kaifeng
Peng Lei
- Recruiting
Kaifeng Central Hospital
Kaifeng
Yong'an Zhou
- Recruiting
Kaifeng Hospital of Traditional Chinese Medicine
Kaifeng
Qinghua Zhao
- Recruiting
Lankao First Hospital Group
Kaifeng
Bing Zhang
- Recruiting
Qixian People's Hospital
Kaifeng
Xuelong Liang
- Recruiting
The People's Hospital of Weishi
Kaifeng
Kaiqin Liu
- Recruiting
Tongxu County People's Hospital
Kaifeng
Ying Tang
- Recruiting
Weishi County People's Hospital
Kaifeng
Hongxia Zhu
- Recruiting
Linyi Hospital of Traditional Chinese Medicine
Linyi
Hezheng Shen
- Recruiting
Linyi People's Hospital
Linyi
Feng Gao
- Recruiting
Linying County People's Hospital
Luohe
Yadong Xing
- Recruiting
Luohe Central Hospital
Luohe
Yuli Meng
- Recruiting
Luanchuan County People's Hospital
Luoyang
Guangsong Li
- Recruiting
Luoning County People's Hospital
Luoyang
Xiubin Hao
- Recruiting
Luoyang Central Hospital
Luoyang
Guoqiang Zhang
- Recruiting
Luoyang First People's Hospital
Luoyang
Hua Li
- Recruiting
Luoyang Third People's Hospital
Luoyang
Hongbo Ji
- Recruiting
Ruyang County People's Hospital
Luoyang
Xianwei Shang
- Recruiting
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang
Xinjun Hu
- Recruiting
Xin'an County People's Hospital
Luoyang
Lanfen Bai
- Recruiting
Yichuan County Hospital of Traditional Chinese Medicine
Luoyang
Xinshui Ye
- Recruiting
Yiyang County People's Hospital
Luoyang
Yaohuan Li
- Recruiting
Dengzhou Central Hospital
Nanyang
Chunge Tian
- Recruiting
Dengzhou People's Hospital
Nanyang
Xinghong Peng
- Recruiting
Fangcheng County People's Hospital
Nanyang
Dong Wang
- Recruiting
Nanyang Central Hospital
Nanyang
Xizeng Zhu
- Recruiting
Nanyang First People's Hospital
Nanyang
Daimeng Shi
- Recruiting
Nanyang Oilfield General Hospital
Nanyang
Qiaoli Yu
- Recruiting
Nanyang Second General Hospital
Nanyang
Xuexiang Wang
- Recruiting
Nanzhao County People's Hospital
Nanyang
Changliang Huang
- Recruiting
Neixiang County People's Hospital
Nanyang
Xiaobo Li
- Recruiting
Sheqi County People's Hospital
Nanyang
Qinglin Zhou
- Recruiting
Tanghe County People's Hospital
Nanyang
Hongxun He
- Recruiting
The First Affiliated Hospital of Nanyang Medical College
Nanyang
Yu Zhang
- Recruiting
Xinye County People's Hospital
Nanyang
Ruichao Li
- Recruiting
Xixia County People's Hospital
Nanyang
Yongling Qiao
- Recruiting
Zhenping People's Hospital
Nanyang
Liguo Yang
- Recruiting
Ningbo Medical Center Iihuili hospital
Ningbo
Hua Ye
- Recruiting
General Hospital Of Pingmei Shenma Group
Pingdingshan
Guodong Zhang
- Recruiting
Lushan County People's Hospital
Pingdingshan
Yin Liu
- Recruiting
People's Hospital of Baofeng
Pingdingshan
Zengyan Yang
- Recruiting
Pingdingshan First People's Hospital
Pingdingshan
Hongde Ma
- Recruiting
Ruzhou First People's Hospital
Pingdingshan
Dongdong Yang
- Recruiting
Ye County People's Hospital
Pingdingshan
Lin Zhou
- Recruiting
Pingdu Municipal People's Hospital
Pingdu
Shuilin Wang
- Recruiting
Anyang District Hospital
Pujiang
Shuli Jin
- Recruiting
Chinese Medicine Hospital of puyang
Pujiang
Jing Wang
- Recruiting
Fanxian People's Hospital
Pujiang
Xianliang Sang
- Recruiting
Nanle County People's Hospital
Pujiang
Zhibo Ren
- Recruiting
Puyang People's Hospital
Pujiang
Xiangan Song
- Recruiting
The Fifth People's Hospital of Puyang City
Pujiang
Weina Zhang
- Recruiting
People's Hospital of Rizhao
Rizhao
Tao Ding
- Recruiting
Huanghe Sanmenxia Hospital
Sanmenxia
Huanhuan Su
- Recruiting
Sanmenxia Central Hospital
Sanmenxia
Xiaoping Dong
- Recruiting
The First People's Hospital of Lingbao
Sanmenxia
Nana Meng
- Recruiting
The Sixth People's Hospital of Lingbao
Sanmenxia
Wanfeng Wang
- Recruiting
Yimei Group General Hospital
Sanmenxia
Jihong Li
- Recruiting
Minquan County Hospital of Traditional Chinese Medicine
Shangqiu
Shifeng Han
- Recruiting
Minquan County People's Hospital
Shangqiu
Yong Cui
- Recruiting
Second People's Hospital Xiayi Country
Shangqiu
Jingwen Sun
- Recruiting
Shangqiu Fourth People's Hospital
Shangqiu
Fajun Jia
- Recruiting
Shangqiu Hospital of Traditional Chinese Medicine
Shangqiu
Xiaolei Zhu
- Recruiting
Shangqiu Municipal Hospital
Shangqiu
Shixi Zhang
- Recruiting
Shangqiu Third People's Hospital
Shangqiu
Kun Lu
- Recruiting
Sui County People's Hospital
Shangqiu
Yanling Yang
- Recruiting
Suixian County Hospital of Traditional Chinese Medicine
Shangqiu
Hongbo Wang
- Recruiting
The First People's Hospital of Shangqiu
Shangqiu
Yaqing Liu
- Recruiting
The People's Hospital of Yucheng County
Shangqiu
Shengli Ma
- Recruiting
Xiayi County People's Hospital
Shangqiu
Yu Zhao
- Recruiting
Yongcheng Central Hospital
Shangqiu
Houfeng Zhai
- Recruiting
Yucheng County People's Hospital
Shangqiu
Mintian Wu
- Recruiting
Zhecheng People's Hospital
Shangqiu
Jianguo Wang
- Recruiting
Zhecheng Traditional Chinese Medicine Hospital Co., Ltd.
Shangqiu
Caiying Luo
- Recruiting
Changyuan County People's Hospital
Xinxiang
Wuxue Niu
- Recruiting
Huixian People's Hospital
Xinxiang
Fuqiang Li
- Recruiting
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang
Daokun Yang
- Recruiting
The Third Affiliated Hospital of Xinxiang Medical University
Xinxiang
Qian Dou
- Recruiting
Xinxiang First People's Hospital
Xinxiang
Yali Yang
- Recruiting
Xinxiang Infectious Disease Hospital
Xinxiang
Zhengyan Wen
- Recruiting
Yanjin County People's Hospital
Xinxiang
Gaoxian Li
- Recruiting
Guangshan County People's Hospital
Xinyang
Zhaohai Zeng
- Recruiting
Gushi County People's Hospital
Xinyang
Mingren Shi
- Recruiting
Huaibin County People's Hospital
Xinyang
Jianye Ding
- Recruiting
Huangchuan County People's Hospital
Xinyang
Jianhong Wu
- Recruiting
Luoshan County People's Hospital
Xinyang
Jianzhi Gu
- Recruiting
Xinyang Central Hospital
Xinyang
Haiyan Chen
- Recruiting
Xinyang Specialized Hospital for Infectious Diseases
Xinyang
Honglei Li
- Recruiting
Xixian People's Hospital
Xinyang
Wenhua Zhai
- Recruiting
Changge People's Hospital
Xuchang
Huage Zhao
- Recruiting
Xiangcheng County Traditional Chinese Medicine Hospital
Xuchang
Jianhong Yang
- Recruiting
Xiangcheng People's Hospital
Xuchang
Xueqin Yan
- Recruiting
Xuchang Central Hospital
Xuchang
Weihong Li
- Recruiting
Xuchang People's Hospital
Xuchang
Xia Zhang
- Recruiting
Yanling County People's Hospital
Xuchang
Wei Zhang
- Recruiting
Yanling County Traditional Chinese Medicine Hospital
Xuchang
Yongzhen Tian
- Recruiting
Yuzhou Central Hospital
Xuchang
Qianqian Chen
- Recruiting
Yuzhou City People's Hospital
Xuchang
Hongmin Si
- Recruiting
Chinese People's Liberation Army Joint Logistics Support Force 970 Hospital,
Yantai
Yi Zhao
- Recruiting
Jiaozuo People's Hospital
Yantai
Jikang Yang
- Recruiting
Yantai Qishan Hospital
Yantai
Haifeng Yu
- Recruiting
Gongyi City People's Hospital
Zhengzhou
Li Yang
- Recruiting
The First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou
Suping Ma
- Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou
Huijiang Yu
- Recruiting
The First People's Hospit of Zhengzhou
Zhengzhou
Shujun Wang
- Recruiting
The Second Affiliated Hospital of Zhengzhou University
Zhengzhou
Gaofeng Lu
- Recruiting
The Six People's Hospit of Zhengzhou
Zhengzhou
Guangming Li
- Recruiting
The Third People's Hospit of Zhengzhou
Zhengzhou
Dan Zhao
- Recruiting
Third Affiliated Hospital of Henan University of Traditional Chinese Medicine
Zhengzhou
Yansheng Li
- Recruiting
Xingyang People's Hospital
Zhengzhou
Gaoyu Chen
- Recruiting
Zhengzhou Central Hospital
Zhengzhou
Huili Wu
- Recruiting
Zhengzhou Traditional Chinese Medicine Hospital
Zhengzhou
Hongwei Luo
- Recruiting
Zhongmu County Hospital of Traditional Chinese Medicine
Zhengzhou
Guoqiang Liang
- Recruiting
Zhongmu County People's Hospital
Zhengzhou
Qiaoxia Chen
- Recruiting
Zhongshan Second People's Hospital
Zhongshan
Qianhua Zhang
- Recruiting
Dancheng County People's Hospital
Zhoukou
Qi Yang
- Recruiting
Fugou County People's Hospital
Zhoukou
Baoping Xu
- Recruiting
Shenqiu People's Hospital
Zhoukou
Xianyang Li
- Recruiting
Taikang County People's Hospital
Zhoukou
Xueqiang Liu
- Recruiting
The Frist People's Hospital Of Xiangcheng
Zhoukou
Hongwei Wang
- Recruiting
The People's Hospital Of Luyi
Zhoukou
Gaoju Li
- Recruiting
Xihua County Hospital of Traditional Chinese Medicine
Zhoukou
Rui Yin
- Recruiting
Xihua County People's Hospital
Zhoukou
Yanfang Zou
- Recruiting
Zhoukou Central Hospital
Zhoukou
Jiaqi Zhang
- Recruiting
Zhoukou Hospital Of TCM
Zhoukou
Jiawei Zhang
- Recruiting
Zhoukou Specialized Disease Hospital
Zhoukou
Mengshan Jia
- Recruiting
People's Hospital of Queshan
Zhumadian
Ruinian Zhang
- Recruiting
Pingyu County People's Hospital
Zhumadian
Jingzhen Zhang
- Recruiting
Runan County Hospital of Traditional Chinese Medicine
Zhumadian
Junling Han
- Recruiting
Shangcai County People's Hospital
Zhumadian
Weiping Li
- Recruiting
The 990th Hospital of the Joint Logistics Support Force of the PLA
Zhumadian
Chun Yuan
- Recruiting
The People's Hospital Of Biyang Country
Zhumadian
Wei Zhang
- Recruiting
Xincai County People's Hospital
Zhumadian
Shumei Guo
- Recruiting
Xincai Medical University
Zhumadian
Daliang Yang
- Recruiting
Xiping County People's Hospital
Zhumadian
Junping Chen
- Recruiting
Zhengyang County People's Hospital
Zhumadian
Minghui Yu
- Recruiting
Zhumadian Central Hospital
Zhumadian
Guifu Shi
- Recruiting
Zhumadian Traditional Chinese Medicine Hospital
Zhumadian
Yufu Wang
- Recruiting
Zibo Central Hospital
Zibo
Yanqing Xing
- Recruiting
Zibo Infectious Diseases Hospital (Zibo Fourth People's Hospital)
Zibo
Gang Li
About this study
This study is a multicenter, prospective, observational real-world study designed to investigate and analyze the current treatment patterns of chronic hepatitis B (CHB) across 200 hospitals in China. By comparing patient outcomes under different therapeutic regimens, it aims to provide high-quality evidence-based medical data to optimize CHB treatment strategies and follow-up protocols, ultimately contributing to the advancement of a functional cure for chronic hepatitis B.
- Conditions
- Chronic Hepatitis b
- Being tested
- ETV,TDF,TAF,TMF, Peginterferon α-2b injection
- Medical subject headings
- Hepatitis B, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ETV,TDF,TAF,TMFDrug
treated with entecavir (ETV), tenofovir disoproxil fumarate (TDF), tenofovir alafenamide fumarate (TAF), or tenofovir amibufenamide (TMF)
Peginterferon α-2b injectionDrug
treated with Peginterferon α-2b injection
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | Not described Receives: Drug: ETV,TDF,TAF,TMF | |
| Group 2 | Not described Receives: Drug: Peginterferon α-2b injection |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of patients with HBsAg-associated HCC post-therapy
Measured: Week 4-240
Hepatocellular Carcinoma (HCC) Incidence
Measured: Week 4-240
Secondary outcomes (13)
Number of chronic hepatitis B (CHB) patients with accurate knowledge/awareness of HBV
Measured: Week 4-240
Rate of HBsAg seroclearance
Measured: Week 4-240
HBsAg seroconversion rate
Measured: Week 4-240
Number of patients with altered HBsAg levels post-treatment
Measured: Week 4-240
Number of patients with HBsAg level decline from baseline
Measured: Week 4-240
HBeAg seroconversion rate
Measured: Week 4-240
HBV DNA
Measured: Week 4-240
Liver fibrosis improvement rate
Measured: Week 4-240
Incidence of liver cirrhosis
Measured: Week 4-240
Incidence of decompensated cirrhosis
Measured: Week 4-240
Incidence of decompensation-related complications
Measured: Week 4-240
Liver transplantation incidence rate
Measured: Week 4-240
Post-treatment relapse rate
Measured: Week 4-240
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Sep 2025
- Study start3 Jun 2024
- Primary completion30 Jun 2032 (estimated)
- Study completion31 Dec 2032 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Hepatitis bStudies of the same condition, open and under way.
- More trials run by The First Affiliated Hospital of Zhengzhou UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 15,000 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hongxia Liang, The First Affiliated Hospital of Zhengzhou University
- Investigators
- Hongxia Liang, Principal investigator, The First Affiliated Hospital of Zhengzhou University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07169656
- Sponsor's protocol ID
- 2024-KY-0976-001
- Status last verified
- Sep 2025
- First submitted
- 24 Jun 2025
- Last updated
- 12 Sep 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
- ClinicalTrials.gov ID
- NCT07169656
- Acronym / sponsor ID
- 2024-KY-0976-001
- Conditions
- Chronic Hepatitis b
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 15,000 participants (estimated)
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou UniversityUniversity, hospital or other
- Study start
- 3 Jun 2024 (actual)
- Primary completion
- 30 Jun 2032 (estimated)
- Study completion
- 31 Dec 2032 (estimated)
- First posted
- 12 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is a multicenter, prospective, observational real-world study designed to investigate and analyze the current treatment patterns of chronic hepatitis B (CHB) across 200 hospitals in China. By comparing patient outcomes under different therapeutic regimens, it aims to provide high-quality evidence-based medical data to optimize CHB treatment strategies and follow-up protocols, ultimately contributing to the advancement of a functional cure for chronic hepatitis B.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group 1 | – | Drug: ETV,TDF,TAF,TMF |
| Group 2 | – | Drug: Peginterferon α-2b injection |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients were selected from chronic hepatitis B (CHB) cases across 200 national hospitals
Key inclusion criteria (1 listed)
- 1.Chronic HBV infection (HBsAg-positive for ≥6 months); 2.Age ≥18 years; 3.Patients who, based on real-world clinical practice needs, are planned or currently receiving treatment with:Entecavir (ETV),Tenofovir disoproxil fumarate (TDF),Tenofovir alafenamide fumarate (TAF),Tenofovir amibufenamide (TMF) OR Pegylated interferon α-2b-naïve patients OR Patients re-initiating pegylated interferon α-2b therapy; 4.Written informed consent obtained from the patient.
Key exclusion criteria (1 listed)
- 1.Severe hepatic dysfunction or decompensated cirrhosis; 2.Concurrent participation in other clinical trials; 3.Hepatocellular carcinoma (HCC).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ETV,TDF,TAF,TMFtreated with entecavir (ETV), tenofovir disoproxil fumarate (TDF), tenofovir alafenamide fumarate (TAF), or tenofovir amibufenamide (TMF) | Drug | Group 1 |
| Peginterferon α-2b injectiontreated with Peginterferon α-2b injection | Drug | Group 2 |
Primary outcome
Percentage of patients with HBsAg-associated HCC post-therapy
Time frame: Week 4-240
Hepatocellular Carcinoma (HCC) Incidence
Time frame: Week 4-240
13 secondary outcomes
Number of chronic hepatitis B (CHB) patients with accurate knowledge/awareness of HBV
Time frame: Week 4-240
Rate of HBsAg seroclearance
Time frame: Week 4-240
HBsAg seroconversion rate
Time frame: Week 4-240
Number of patients with altered HBsAg levels post-treatment
Time frame: Week 4-240
Number of patients with HBsAg level decline from baseline
Time frame: Week 4-240
HBeAg seroconversion rate
Time frame: Week 4-240
HBV DNA
Time frame: Week 4-240
Liver fibrosis improvement rate
Time frame: Week 4-240
Incidence of liver cirrhosis
Time frame: Week 4-240
Incidence of decompensated cirrhosis
Time frame: Week 4-240
Incidence of decompensation-related complications
Time frame: Week 4-240
Liver transplantation incidence rate
Time frame: Week 4-240
Post-treatment relapse rate
Time frame: Week 4-240
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Chronic Hepatitis b
Active, not recruitingPhase 2
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
Chronic Hepatitis B Virus Infection, Hepatitis B
RecruitingObservational study
Evaluation of Patients With Liver Disease
Hepatitis D, Hepatitis C
Active, not recruitingPhase 2
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
Hepatitis B
Active, not recruitingPhase 2
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
Hepatitis B
Enrolling by invitationPhase 1
A Phase I Clinical Trial of CPU-YL01 Injection in Patients With Chronic Hepatitis B.
Chronic Hepatitis B
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Hongxia Liang principal investigator
The First Affiliated Hospital of Zhengzhou University
162 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Hepatitis b, run by The First Affiliated Hospital of Zhengzhou University at 162 sites in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 162 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hongxia Liang (18595871806, hxliang@zzu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of patients with HBsAg-associated HCC post-therapy (time frame: Week 4-240). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2025.